The treatment of combination chemotherapy-resistant Hodgkin disease with single-agent vinblastine.
D000293:Adolescent; D000328:Adult; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005069:Evaluation Studies as Topic; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008297:Male; D014747:Vinblastine / Q000008:administration & dosage / Q000627:therapeutic use*
D014747:Vinblastine